» Articles » PMID: 30697455

Impact of Donor Characteristics on the Quality of Bone Marrow As a Source of Mesenchymal Stromal Cells

Overview
Journal Am J Stem Cells
Date 2019 Jan 31
PMID 30697455
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the therapeutic use of mesenchymal stromal cells (MSC) has generated a valuable number of scientific studies that delve into their biological characteristics and their potential in regenerative medicine; however, the impact of the clinical characteristics of tissue donors, from which these cells are isolated, on their potential in applied clinical research is not yet clear. The objective of this study was to evaluate the impact of the clinical characteristics of bone marrow donors on the quality of this tissue as a source of MSC for therapeutic use. Human MSC were isolated, characterized and cultured (according to ISCT criteria) from bone marrow samples from volunteer donors (n = 70) attending the Department of Orthopedics and Traumatology of the Hospital Universitario San Ignacio (Bogota, Colombia) for surgery of prosthetic hip replacement that agreed to participate voluntarily in the study. Donor data such as age, gender, weight, smoker and type of anesthesia used during the surgical procedure were recorded, and the impact of these characteristics on the volume of tissue collection, mononuclear cell count and confluence time of cells with fibroblastoid morphology was evaluated. Correlation coefficients between quantitative variables were calculated with Spearman's correlation test, and the association between qualitative and quantitative variables was evaluated with biserial correlation coefficient. A significant correlation was observed between the age of the donors and the time necessary to obtain confluent cells in vitro (r = 0.2489, P = 0.0377); similarly, the correlation between the volume of bone marrow collected and the number of mononuclear cells obtained was significant (r = 0.7101, P = 0.0001). Although a negative correlation tendency was observed between the mononuclear cell count and the confluence time, this was not significant (r = -0.2041, P = 0.0950). No significant associations were observed between gender, smoking status or type of anesthesia and the expansion characteristics of human mesenchymal stromal cells. Bone marrow donor age and the tissue collection volume impact the time of obtaining MSC in vitro and the mononuclear cell count with which the culture starts. These conditions must be considered when the bone marrow is selected as the tissue for obtaining MSC.

Citing Articles

The Effects of Gender on Mesenchymal Stromal Cell (MSC) Proliferation and Differentiation In Vitro: A Systematic Review.

Vogt A, Faher A, Kucharczak J, Birch M, McCaskie A, Khan W Int J Mol Sci. 2025; 25(24.

PMID: 39769346 PMC: 11677156. DOI: 10.3390/ijms252413585.


Enhancement of Chondrogenic Markers by Exosomes Derived from Cultured Human Synovial Fluid-Derived Cells: A Comparative Analysis of 2D and 3D Conditions.

Han B, Fang W, Yang Z, Wang Y, Zhao S, Hoang B Biomedicines. 2023; 11(12).

PMID: 38137366 PMC: 10740632. DOI: 10.3390/biomedicines11123145.


Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.

Keung C, Nguyen T, Lim R, Gerstenmaier A, Sievert W, Moore G EBioMedicine. 2023; 98:104879.

PMID: 38042747 PMC: 10755113. DOI: 10.1016/j.ebiom.2023.104879.


Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments.

Bowles-Welch A, Jimenez A, Stevens H, Frey Rubio D, Kippner L, Yeago C Bone Rep. 2023; 18:101656.

PMID: 37425195 PMC: 10323188. DOI: 10.1016/j.bonr.2023.101656.


Doxorubicin Activity Is Modulated by Traditional Herbal Extracts in a 2D and 3D Multicellular Sphere Model of Leukemia.

Corzo Parada L, Uruena C, Leal-Garcia E, Barreto A, Ballesteros-Ramirez R, Rodriguez-Pardo V Pharmaceutics. 2023; 15(6).

PMID: 37376139 PMC: 10302921. DOI: 10.3390/pharmaceutics15061690.


References
1.
Bieback K, Kern S, Kluter H, Eichler H . Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004; 22(4):625-34. DOI: 10.1634/stemcells.22-4-625. View

2.
Doucet C, Ernou I, Zhang Y, Llense J, Begot L, Holy X . Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005; 205(2):228-36. DOI: 10.1002/jcp.20391. View

3.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

4.
Abdallah B, Kassem M . Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2007; 15(2):109-16. DOI: 10.1038/sj.gt.3303067. View

5.
Sun Y, Li W, Lu Z, Chen R, Ling J, Ran Q . Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J. 2011; 25(5):1474-85. PMC: 3079301. DOI: 10.1096/fj.10-161497. View